YZYBIO-B(02496): Shi Jian has been elected as a workers' representative supervisor.
Youzhiyou Biology-B (02496) announced that Dr. Wang Tao has resigned from the position of employee representative supervisor of the company due to personal career development reasons, effective from December 31, 2025. Dr. Shi Jian, Director of the Translational Medicine Department of the company, was democratically elected as the employee representative supervisor of the second supervisory board on December 31, 2025. Dr. Shi's term will be effective from December 31, 2025, and will expire at the end of the second supervisory board meeting.
YZYBIO-B(02496) Announcement: Dr. Wang Tao has resigned from his position as the employee representative supervisor of the company for personal career development reasons, effective from December 31, 2025. Dr. Shi Jian, Director of the Translational Medicine Department of the company, was democratically elected as the employee representative supervisor for the 2nd Supervisory Board, effective from December 31, 2025. Dr. Shi's term will end when the 2nd Supervisory Board concludes.
Related Articles
Ming Yuan Cloud (00909) spent HK$9.79 million on repurchasing 3 million shares on December 31st.
PUBLIC FIN HOLD (00626): Zheng Guoqian resigns as non-executive director.
The mid-term growth momentum is underestimated. Goldman Sachs Group, Inc. reaffirmed a "buy" rating on Ulta Beauty (ULTA.US).
Ming Yuan Cloud (00909) spent HK$9.79 million on repurchasing 3 million shares on December 31st.
PUBLIC FIN HOLD (00626): Zheng Guoqian resigns as non-executive director.
The mid-term growth momentum is underestimated. Goldman Sachs Group, Inc. reaffirmed a "buy" rating on Ulta Beauty (ULTA.US).
